Vertex Pharmaceuticals Inc (MIL:1VRTX)
€ 441.05 -2.05 (-0.46%) Market Cap: 112.08 Bil Enterprise Value: 107.49 Bil PE Ratio: 0 PB Ratio: 7.54 GF Score: 73/100

Vertex Pharmaceuticals Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 19, 2020 / 02:05PM GMT
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Well, good morning, everyone, or good afternoon, depending on where you are in the world. I'm Michael Yee, and thank you for joining us on this exciting session here at the 2020 Virtual Jefferies London Healthcare Conference, and you see I'm here virtually in London right behind me.

I wanted to introduce my friends here at Vertex Pharmaceuticals. We have the President and CEO, Reshma Kewalramani. I think I got that right, I practiced. And also, of course, everyone knows a good friend, Michael Partridge, who runs the IR group at Vertex.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

I just wanted to take a step back and maybe just start with Reshma. 2020 has been a bit of an unprecedented year for everyone. But I would point out that Vertex has been quite a standout because you have executed quite well throughout the year, even during COVID. So maybe I just wanted to take a step back and turn it over to you and say, tell us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot